Clinical Trial Update: A Non-interventional Implementation Study to Evaluate Treatment With Inclisiran (Leqvio®) and Other Lipid Lowering Treatments in a Real-world Setting

View source ↗

Summary

A completed non-interventional study assessing Inclisiran (Leqvio) and other lipid-lowering therapies in real-world treatment of hypercholesterolemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia

Drugs mentioned

• LEQVIO (inclisiran)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Hypercholesterolemia | Status: COMPLETED